nodes	percent_of_prediction	percent_of_DWPC	metapath
Mirtazapine—ADRB1—type 1 diabetes mellitus	0.648	1	CbGaD
Mirtazapine—HTR7—umbilical artery—type 1 diabetes mellitus	0.0174	0.234	CbGeAlD
Mirtazapine—HTR2A—arteriole—type 1 diabetes mellitus	0.00622	0.0838	CbGeAlD
Mirtazapine—SLC6A2—autonomic nervous system—type 1 diabetes mellitus	0.00443	0.0597	CbGeAlD
Mirtazapine—HTR7—autonomic nervous system—type 1 diabetes mellitus	0.00427	0.0575	CbGeAlD
Mirtazapine—Cerebrovascular disorder—Ramipril—type 1 diabetes mellitus	0.00383	0.0377	CcSEcCtD
Mirtazapine—HTR3A—nerve—type 1 diabetes mellitus	0.00371	0.05	CbGeAlD
Mirtazapine—Cerebral ischaemia—Ramipril—type 1 diabetes mellitus	0.00355	0.0348	CcSEcCtD
Mirtazapine—SLC6A3—nerve—type 1 diabetes mellitus	0.00309	0.0416	CbGeAlD
Mirtazapine—HTR7—peripheral nervous system—type 1 diabetes mellitus	0.00308	0.0415	CbGeAlD
Mirtazapine—HTR2A—autonomic nervous system—type 1 diabetes mellitus	0.00266	0.0359	CbGeAlD
Mirtazapine—Parosmia—Ramipril—type 1 diabetes mellitus	0.00264	0.026	CcSEcCtD
Mirtazapine—Bone marrow depression—Ramipril—type 1 diabetes mellitus	0.00254	0.0249	CcSEcCtD
Mirtazapine—SLC6A2—nerve—type 1 diabetes mellitus	0.00249	0.0336	CbGeAlD
Mirtazapine—HTR7—nerve—type 1 diabetes mellitus	0.0024	0.0324	CbGeAlD
Mirtazapine—DRD2—nerve—type 1 diabetes mellitus	0.00227	0.0306	CbGeAlD
Mirtazapine—ADRA2A—peripheral nervous system—type 1 diabetes mellitus	0.00226	0.0304	CbGeAlD
Mirtazapine—Ageusia—Ramipril—type 1 diabetes mellitus	0.00212	0.0208	CcSEcCtD
Mirtazapine—Disturbance in attention—Ramipril—type 1 diabetes mellitus	0.00198	0.0194	CcSEcCtD
Mirtazapine—HTR2A—peripheral nervous system—type 1 diabetes mellitus	0.00192	0.0259	CbGeAlD
Mirtazapine—Cough increased—Ramipril—type 1 diabetes mellitus	0.00187	0.0184	CcSEcCtD
Mirtazapine—Glossitis—Ramipril—type 1 diabetes mellitus	0.00186	0.0183	CcSEcCtD
Mirtazapine—HTR3A—islet of Langerhans—type 1 diabetes mellitus	0.0018	0.0242	CbGeAlD
Mirtazapine—Salivary hypersecretion—Ramipril—type 1 diabetes mellitus	0.00166	0.0164	CcSEcCtD
Mirtazapine—Urine output increased—Ramipril—type 1 diabetes mellitus	0.00155	0.0152	CcSEcCtD
Mirtazapine—HTR2A—nerve—type 1 diabetes mellitus	0.0015	0.0202	CbGeAlD
Mirtazapine—Polyuria—Ramipril—type 1 diabetes mellitus	0.00142	0.0139	CcSEcCtD
Mirtazapine—Gastroenteritis—Ramipril—type 1 diabetes mellitus	0.0014	0.0138	CcSEcCtD
Mirtazapine—Deafness—Ramipril—type 1 diabetes mellitus	0.00139	0.0137	CcSEcCtD
Mirtazapine—Libido decreased—Ramipril—type 1 diabetes mellitus	0.00134	0.0132	CcSEcCtD
Mirtazapine—Amnesia—Ramipril—type 1 diabetes mellitus	0.00132	0.013	CcSEcCtD
Mirtazapine—Dermatitis exfoliative—Ramipril—type 1 diabetes mellitus	0.00132	0.013	CcSEcCtD
Mirtazapine—Arthritis—Ramipril—type 1 diabetes mellitus	0.00128	0.0126	CcSEcCtD
Mirtazapine—Hyponatraemia—Ramipril—type 1 diabetes mellitus	0.00125	0.0123	CcSEcCtD
Mirtazapine—Disturbance in sexual arousal—Ramipril—type 1 diabetes mellitus	0.00123	0.0121	CcSEcCtD
Mirtazapine—Liver function test abnormal—Ramipril—type 1 diabetes mellitus	0.00115	0.0113	CcSEcCtD
Mirtazapine—Orthostatic hypotension—Ramipril—type 1 diabetes mellitus	0.00114	0.0112	CcSEcCtD
Mirtazapine—Toxic epidermal necrolysis—Ramipril—type 1 diabetes mellitus	0.00112	0.011	CcSEcCtD
Mirtazapine—Gastritis—Ramipril—type 1 diabetes mellitus	0.0011	0.0108	CcSEcCtD
Mirtazapine—Influenza—Ramipril—type 1 diabetes mellitus	0.00108	0.0106	CcSEcCtD
Mirtazapine—Asthma—Ramipril—type 1 diabetes mellitus	0.00108	0.0106	CcSEcCtD
Mirtazapine—Eosinophilia—Ramipril—type 1 diabetes mellitus	0.00106	0.0105	CcSEcCtD
Mirtazapine—Pancreatitis—Ramipril—type 1 diabetes mellitus	0.00105	0.0104	CcSEcCtD
Mirtazapine—Sweating increased—Ramipril—type 1 diabetes mellitus	0.00105	0.0103	CcSEcCtD
Mirtazapine—Angina pectoris—Ramipril—type 1 diabetes mellitus	0.00105	0.0103	CcSEcCtD
Mirtazapine—Bronchitis—Ramipril—type 1 diabetes mellitus	0.00103	0.0102	CcSEcCtD
Mirtazapine—ADRB1—cardiovascular system—type 1 diabetes mellitus	0.00103	0.0138	CbGeAlD
Mirtazapine—Pancytopenia—Ramipril—type 1 diabetes mellitus	0.00102	0.01	CcSEcCtD
Mirtazapine—Neutropenia—Ramipril—type 1 diabetes mellitus	0.00101	0.00988	CcSEcCtD
Mirtazapine—Erectile dysfunction—Ramipril—type 1 diabetes mellitus	0.00099	0.00973	CcSEcCtD
Mirtazapine—HTR2B—cardiovascular system—type 1 diabetes mellitus	0.000982	0.0132	CbGeAlD
Mirtazapine—Photosensitivity reaction—Ramipril—type 1 diabetes mellitus	0.000982	0.00964	CcSEcCtD
Mirtazapine—Weight increased—Ramipril—type 1 diabetes mellitus	0.000979	0.00961	CcSEcCtD
Mirtazapine—Stevens-Johnson syndrome—Ramipril—type 1 diabetes mellitus	0.000951	0.00934	CcSEcCtD
Mirtazapine—Acute coronary syndrome—Ramipril—type 1 diabetes mellitus	0.000945	0.00928	CcSEcCtD
Mirtazapine—DRD2—retina—type 1 diabetes mellitus	0.00094	0.0127	CbGeAlD
Mirtazapine—Myocardial infarction—Ramipril—type 1 diabetes mellitus	0.00094	0.00923	CcSEcCtD
Mirtazapine—Jaundice—Ramipril—type 1 diabetes mellitus	0.000935	0.00918	CcSEcCtD
Mirtazapine—Stomatitis—Ramipril—type 1 diabetes mellitus	0.000935	0.00918	CcSEcCtD
Mirtazapine—Urinary tract infection—Ramipril—type 1 diabetes mellitus	0.000932	0.00915	CcSEcCtD
Mirtazapine—Conjunctivitis—Ramipril—type 1 diabetes mellitus	0.000932	0.00915	CcSEcCtD
Mirtazapine—Sweating—Ramipril—type 1 diabetes mellitus	0.000919	0.00903	CcSEcCtD
Mirtazapine—Hepatobiliary disease—Ramipril—type 1 diabetes mellitus	0.000907	0.00891	CcSEcCtD
Mirtazapine—Epistaxis—Ramipril—type 1 diabetes mellitus	0.000904	0.00888	CcSEcCtD
Mirtazapine—Sinusitis—Ramipril—type 1 diabetes mellitus	0.0009	0.00884	CcSEcCtD
Mirtazapine—Agranulocytosis—Ramipril—type 1 diabetes mellitus	0.000895	0.00879	CcSEcCtD
Mirtazapine—HTR1A—cardiovascular system—type 1 diabetes mellitus	0.00088	0.0119	CbGeAlD
Mirtazapine—ADRA2C—nephron tubule—type 1 diabetes mellitus	0.000861	0.0116	CbGeAlD
Mirtazapine—Hepatitis—Ramipril—type 1 diabetes mellitus	0.000861	0.00845	CcSEcCtD
Mirtazapine—ADRA2A—islet of Langerhans—type 1 diabetes mellitus	0.000853	0.0115	CbGeAlD
Mirtazapine—Oedema peripheral—Ramipril—type 1 diabetes mellitus	0.000848	0.00833	CcSEcCtD
Mirtazapine—HTR7—cardiovascular system—type 1 diabetes mellitus	0.000841	0.0113	CbGeAlD
Mirtazapine—HTR7—kidney—type 1 diabetes mellitus	0.000823	0.0111	CbGeAlD
Mirtazapine—Erythema multiforme—Ramipril—type 1 diabetes mellitus	0.000814	0.00799	CcSEcCtD
Mirtazapine—ADRA1A—cardiovascular system—type 1 diabetes mellitus	0.000812	0.0109	CbGeAlD
Mirtazapine—Tinnitus—Ramipril—type 1 diabetes mellitus	0.000803	0.00788	CcSEcCtD
Mirtazapine—Arrhythmia—Ramipril—type 1 diabetes mellitus	0.000769	0.00755	CcSEcCtD
Mirtazapine—Alopecia—Ramipril—type 1 diabetes mellitus	0.000761	0.00747	CcSEcCtD
Mirtazapine—ADRA2C—kidney—type 1 diabetes mellitus	0.000757	0.0102	CbGeAlD
Mirtazapine—Mental disorder—Ramipril—type 1 diabetes mellitus	0.000754	0.00741	CcSEcCtD
Mirtazapine—ADRA2C—pancreas—type 1 diabetes mellitus	0.000752	0.0101	CbGeAlD
Mirtazapine—Malnutrition—Ramipril—type 1 diabetes mellitus	0.000749	0.00736	CcSEcCtD
Mirtazapine—Tension—Ramipril—type 1 diabetes mellitus	0.000735	0.00722	CcSEcCtD
Mirtazapine—Dysgeusia—Ramipril—type 1 diabetes mellitus	0.000734	0.00721	CcSEcCtD
Mirtazapine—Nervousness—Ramipril—type 1 diabetes mellitus	0.000728	0.00715	CcSEcCtD
Mirtazapine—Tremor—Ramipril—type 1 diabetes mellitus	0.000702	0.0069	CcSEcCtD
Mirtazapine—CYP2C8—kidney—type 1 diabetes mellitus	0.000702	0.00945	CbGeAlD
Mirtazapine—Ill-defined disorder—Ramipril—type 1 diabetes mellitus	0.000695	0.00683	CcSEcCtD
Mirtazapine—Agitation—Ramipril—type 1 diabetes mellitus	0.000689	0.00676	CcSEcCtD
Mirtazapine—ADRA1A—lymphoid tissue—type 1 diabetes mellitus	0.000682	0.00919	CbGeAlD
Mirtazapine—Malaise—Ramipril—type 1 diabetes mellitus	0.000676	0.00664	CcSEcCtD
Mirtazapine—Vertigo—Ramipril—type 1 diabetes mellitus	0.000673	0.00661	CcSEcCtD
Mirtazapine—Syncope—Ramipril—type 1 diabetes mellitus	0.000672	0.0066	CcSEcCtD
Mirtazapine—Leukopenia—Ramipril—type 1 diabetes mellitus	0.000671	0.00659	CcSEcCtD
Mirtazapine—Metixene—CHRM2—type 1 diabetes mellitus	0.000664	1	CrCbGaD
Mirtazapine—Palpitations—Ramipril—type 1 diabetes mellitus	0.000662	0.0065	CcSEcCtD
Mirtazapine—Loss of consciousness—Ramipril—type 1 diabetes mellitus	0.000659	0.00647	CcSEcCtD
Mirtazapine—Cough—Ramipril—type 1 diabetes mellitus	0.000654	0.00642	CcSEcCtD
Mirtazapine—Convulsion—Ramipril—type 1 diabetes mellitus	0.000649	0.00638	CcSEcCtD
Mirtazapine—Arthralgia—Ramipril—type 1 diabetes mellitus	0.000638	0.00627	CcSEcCtD
Mirtazapine—Chest pain—Ramipril—type 1 diabetes mellitus	0.000638	0.00627	CcSEcCtD
Mirtazapine—Myalgia—Ramipril—type 1 diabetes mellitus	0.000638	0.00627	CcSEcCtD
Mirtazapine—CYP2C9—cardiovascular system—type 1 diabetes mellitus	0.000637	0.00858	CbGeAlD
Mirtazapine—Anxiety—Ramipril—type 1 diabetes mellitus	0.000636	0.00624	CcSEcCtD
Mirtazapine—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 1 diabetes mellitus	0.000634	0.00622	CcSEcCtD
Mirtazapine—Discomfort—Ramipril—type 1 diabetes mellitus	0.00063	0.00619	CcSEcCtD
Mirtazapine—Dry mouth—Ramipril—type 1 diabetes mellitus	0.000624	0.00613	CcSEcCtD
Mirtazapine—HTR2A—retina—type 1 diabetes mellitus	0.00062	0.00836	CbGeAlD
Mirtazapine—Confusional state—Ramipril—type 1 diabetes mellitus	0.000617	0.00606	CcSEcCtD
Mirtazapine—Oedema—Ramipril—type 1 diabetes mellitus	0.000612	0.00601	CcSEcCtD
Mirtazapine—Shock—Ramipril—type 1 diabetes mellitus	0.000602	0.00591	CcSEcCtD
Mirtazapine—Nervous system disorder—Ramipril—type 1 diabetes mellitus	0.0006	0.00589	CcSEcCtD
Mirtazapine—ADRA2A—pancreas—type 1 diabetes mellitus	0.0006	0.00808	CbGeAlD
Mirtazapine—Thrombocytopenia—Ramipril—type 1 diabetes mellitus	0.000599	0.00588	CcSEcCtD
Mirtazapine—Tachycardia—Ramipril—type 1 diabetes mellitus	0.000597	0.00586	CcSEcCtD
Mirtazapine—Skin disorder—Ramipril—type 1 diabetes mellitus	0.000594	0.00583	CcSEcCtD
Mirtazapine—Hyperhidrosis—Ramipril—type 1 diabetes mellitus	0.000591	0.00581	CcSEcCtD
Mirtazapine—Anorexia—Ramipril—type 1 diabetes mellitus	0.000583	0.00573	CcSEcCtD
Mirtazapine—Hypotension—Ramipril—type 1 diabetes mellitus	0.000571	0.00561	CcSEcCtD
Mirtazapine—Musculoskeletal discomfort—Ramipril—type 1 diabetes mellitus	0.000557	0.00547	CcSEcCtD
Mirtazapine—Insomnia—Ramipril—type 1 diabetes mellitus	0.000553	0.00543	CcSEcCtD
Mirtazapine—Paraesthesia—Ramipril—type 1 diabetes mellitus	0.000549	0.00539	CcSEcCtD
Mirtazapine—Dyspnoea—Ramipril—type 1 diabetes mellitus	0.000545	0.00536	CcSEcCtD
Mirtazapine—Somnolence—Ramipril—type 1 diabetes mellitus	0.000544	0.00534	CcSEcCtD
Mirtazapine—Dyspepsia—Ramipril—type 1 diabetes mellitus	0.000538	0.00529	CcSEcCtD
Mirtazapine—Decreased appetite—Ramipril—type 1 diabetes mellitus	0.000532	0.00522	CcSEcCtD
Mirtazapine—Gastrointestinal disorder—Ramipril—type 1 diabetes mellitus	0.000528	0.00519	CcSEcCtD
Mirtazapine—Fatigue—Ramipril—type 1 diabetes mellitus	0.000527	0.00518	CcSEcCtD
Mirtazapine—HTR2A—cardiovascular system—type 1 diabetes mellitus	0.000525	0.00707	CbGeAlD
Mirtazapine—Constipation—Ramipril—type 1 diabetes mellitus	0.000523	0.00514	CcSEcCtD
Mirtazapine—HTR2A—kidney—type 1 diabetes mellitus	0.000513	0.00692	CbGeAlD
Mirtazapine—Feeling abnormal—Ramipril—type 1 diabetes mellitus	0.000504	0.00495	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Ramipril—type 1 diabetes mellitus	0.0005	0.00491	CcSEcCtD
Mirtazapine—Urticaria—Ramipril—type 1 diabetes mellitus	0.000486	0.00477	CcSEcCtD
Mirtazapine—Abdominal pain—Ramipril—type 1 diabetes mellitus	0.000483	0.00475	CcSEcCtD
Mirtazapine—Body temperature increased—Ramipril—type 1 diabetes mellitus	0.000483	0.00475	CcSEcCtD
Mirtazapine—CYP3A4—kidney—type 1 diabetes mellitus	0.000475	0.0064	CbGeAlD
Mirtazapine—CYP2D6—kidney—type 1 diabetes mellitus	0.000468	0.0063	CbGeAlD
Mirtazapine—Hypersensitivity—Ramipril—type 1 diabetes mellitus	0.000451	0.00443	CcSEcCtD
Mirtazapine—Asthenia—Ramipril—type 1 diabetes mellitus	0.000439	0.00431	CcSEcCtD
Mirtazapine—Pruritus—Ramipril—type 1 diabetes mellitus	0.000433	0.00425	CcSEcCtD
Mirtazapine—Diarrhoea—Ramipril—type 1 diabetes mellitus	0.000418	0.00411	CcSEcCtD
Mirtazapine—Dizziness—Ramipril—type 1 diabetes mellitus	0.000404	0.00397	CcSEcCtD
Mirtazapine—Vomiting—Ramipril—type 1 diabetes mellitus	0.000389	0.00382	CcSEcCtD
Mirtazapine—Rash—Ramipril—type 1 diabetes mellitus	0.000386	0.00379	CcSEcCtD
Mirtazapine—Dermatitis—Ramipril—type 1 diabetes mellitus	0.000385	0.00378	CcSEcCtD
Mirtazapine—Headache—Ramipril—type 1 diabetes mellitus	0.000383	0.00376	CcSEcCtD
Mirtazapine—Nausea—Ramipril—type 1 diabetes mellitus	0.000363	0.00357	CcSEcCtD
Mirtazapine—HTR2A—Signaling Pathways—CD86—type 1 diabetes mellitus	1.21e-05	6.9e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling by GPCR—IL2—type 1 diabetes mellitus	1.21e-05	6.9e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—CD86—type 1 diabetes mellitus	1.21e-05	6.89e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	1.21e-05	6.88e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—IGF1—type 1 diabetes mellitus	1.21e-05	6.88e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—CCR5—type 1 diabetes mellitus	1.2e-05	6.86e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling by GPCR—EGFR—type 1 diabetes mellitus	1.2e-05	6.85e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—INS—type 1 diabetes mellitus	1.19e-05	6.79e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—CD86—type 1 diabetes mellitus	1.18e-05	6.76e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—IL2RA—type 1 diabetes mellitus	1.18e-05	6.76e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—TYK2—type 1 diabetes mellitus	1.18e-05	6.75e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling by GPCR—IL2—type 1 diabetes mellitus	1.17e-05	6.71e-05	CbGpPWpGaD
Mirtazapine—DRD2—GPCR downstream signaling—IL2—type 1 diabetes mellitus	1.17e-05	6.7e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—CD80—type 1 diabetes mellitus	1.17e-05	6.69e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—E2F1—type 1 diabetes mellitus	1.17e-05	6.66e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—TYK2—type 1 diabetes mellitus	1.16e-05	6.64e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—NOS3—type 1 diabetes mellitus	1.16e-05	6.62e-05	CbGpPWpGaD
Mirtazapine—HTR2A—GPCR downstream signaling—IL2—type 1 diabetes mellitus	1.16e-05	6.59e-05	CbGpPWpGaD
Mirtazapine—HRH1—GPCR downstream signaling—IL2—type 1 diabetes mellitus	1.15e-05	6.58e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—IGF1—type 1 diabetes mellitus	1.15e-05	6.57e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—E2F1—type 1 diabetes mellitus	1.15e-05	6.55e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—TYK2—type 1 diabetes mellitus	1.15e-05	6.55e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—HBA1—type 1 diabetes mellitus	1.15e-05	6.54e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling by GPCR—EGFR—type 1 diabetes mellitus	1.15e-05	6.54e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—E2F1—type 1 diabetes mellitus	1.14e-05	6.54e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—IGF2—type 1 diabetes mellitus	1.14e-05	6.52e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—NOS3—type 1 diabetes mellitus	1.14e-05	6.52e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—APOC3—type 1 diabetes mellitus	1.14e-05	6.5e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—GPCR downstream signaling—IL2—type 1 diabetes mellitus	1.13e-05	6.46e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—E2F1—type 1 diabetes mellitus	1.12e-05	6.41e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—GSTT1—type 1 diabetes mellitus	1.12e-05	6.38e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Metabolism—INS—type 1 diabetes mellitus	1.12e-05	6.37e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—TYK2—type 1 diabetes mellitus	1.11e-05	6.36e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—KCNJ11—type 1 diabetes mellitus	1.11e-05	6.35e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—ERBB3—type 1 diabetes mellitus	1.11e-05	6.33e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—INS—type 1 diabetes mellitus	1.11e-05	6.32e-05	CbGpPWpGaD
Mirtazapine—HRH3—Signaling Pathways—IL6—type 1 diabetes mellitus	1.1e-05	6.28e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CD86—type 1 diabetes mellitus	1.1e-05	6.28e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—NOS3—type 1 diabetes mellitus	1.09e-05	6.24e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—ERBB3—type 1 diabetes mellitus	1.09e-05	6.23e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—CCR5—type 1 diabetes mellitus	1.09e-05	6.22e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—ERBB3—type 1 diabetes mellitus	1.09e-05	6.21e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—CAT—type 1 diabetes mellitus	1.08e-05	6.19e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—IL2RA—type 1 diabetes mellitus	1.07e-05	6.13e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—CCR5—type 1 diabetes mellitus	1.07e-05	6.12e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—IGF1—type 1 diabetes mellitus	1.07e-05	6.11e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—CCR5—type 1 diabetes mellitus	1.07e-05	6.11e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—ERBB3—type 1 diabetes mellitus	1.07e-05	6.1e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—CD80—type 1 diabetes mellitus	1.07e-05	6.09e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling by GPCR—IL2—type 1 diabetes mellitus	1.07e-05	6.09e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling by GPCR—EGFR—type 1 diabetes mellitus	1.07e-05	6.08e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—TYK2—type 1 diabetes mellitus	1.06e-05	6.07e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—IL2RA—type 1 diabetes mellitus	1.06e-05	6.03e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—IL2RA—type 1 diabetes mellitus	1.05e-05	6.02e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—GCG—type 1 diabetes mellitus	1.05e-05	6e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—GPCR downstream signaling—IL2—type 1 diabetes mellitus	1.05e-05	6e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—CCR5—type 1 diabetes mellitus	1.05e-05	5.99e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling by GPCR—IL2—type 1 diabetes mellitus	1.05e-05	5.99e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—IL2—type 1 diabetes mellitus	1.05e-05	5.98e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—CD80—type 1 diabetes mellitus	1.04e-05	5.96e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—E2F1—type 1 diabetes mellitus	1.04e-05	5.96e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—NOS3—type 1 diabetes mellitus	1.04e-05	5.96e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—GCG—type 1 diabetes mellitus	1.04e-05	5.95e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—IL2RA—type 1 diabetes mellitus	1.03e-05	5.91e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	1.03e-05	5.88e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—IL2—type 1 diabetes mellitus	1.03e-05	5.86e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Metabolism—ALB—type 1 diabetes mellitus	1.02e-05	5.84e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—CD80—type 1 diabetes mellitus	1.02e-05	5.83e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—CD80—type 1 diabetes mellitus	1.02e-05	5.8e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—INS—type 1 diabetes mellitus	1.01e-05	5.76e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—ERBB3—type 1 diabetes mellitus	9.92e-06	5.66e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—TYK2—type 1 diabetes mellitus	9.89e-06	5.65e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—CD80—type 1 diabetes mellitus	9.88e-06	5.64e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—INS—type 1 diabetes mellitus	9.87e-06	5.63e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—CASP3—type 1 diabetes mellitus	9.85e-06	5.62e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—IL2—type 1 diabetes mellitus	9.83e-06	5.61e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Metabolism—NOS3—type 1 diabetes mellitus	9.79e-06	5.59e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling by GPCR—IL6—type 1 diabetes mellitus	9.78e-06	5.58e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CCR5—type 1 diabetes mellitus	9.76e-06	5.57e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—IGF1—type 1 diabetes mellitus	9.76e-06	5.57e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling by GPCR—EGFR—type 1 diabetes mellitus	9.71e-06	5.54e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—NOS3—type 1 diabetes mellitus	9.71e-06	5.54e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—CASP3—type 1 diabetes mellitus	9.69e-06	5.53e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—IL2—type 1 diabetes mellitus	9.68e-06	5.53e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—INS—type 1 diabetes mellitus	9.65e-06	5.51e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling by GPCR—IL6—type 1 diabetes mellitus	9.63e-06	5.5e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—IL2RA—type 1 diabetes mellitus	9.62e-06	5.49e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—INS—type 1 diabetes mellitus	9.6e-06	5.48e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—IGF1—type 1 diabetes mellitus	9.54e-06	5.45e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—IL2—type 1 diabetes mellitus	9.54e-06	5.45e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling by GPCR—EGFR—type 1 diabetes mellitus	9.5e-06	5.42e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—ITPR3—type 1 diabetes mellitus	9.39e-06	5.36e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—INS—type 1 diabetes mellitus	9.34e-06	5.33e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—IGF1—type 1 diabetes mellitus	9.33e-06	5.33e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	9.29e-06	5.3e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—IGF1—type 1 diabetes mellitus	9.28e-06	5.3e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—CASP3—type 1 diabetes mellitus	9.28e-06	5.3e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—IL2—type 1 diabetes mellitus	9.27e-06	5.29e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling by GPCR—EGFR—type 1 diabetes mellitus	9.24e-06	5.27e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling by GPCR—IL6—type 1 diabetes mellitus	9.22e-06	5.26e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—INS—type 1 diabetes mellitus	9.07e-06	5.18e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—IGF1—type 1 diabetes mellitus	9.03e-06	5.16e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—TYK2—type 1 diabetes mellitus	9.01e-06	5.14e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling by GPCR—EGFR—type 1 diabetes mellitus	8.99e-06	5.13e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—CD80—type 1 diabetes mellitus	8.97e-06	5.12e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—GCG—type 1 diabetes mellitus	8.91e-06	5.09e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—CAT—type 1 diabetes mellitus	8.9e-06	5.08e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—CASP3—type 1 diabetes mellitus	8.86e-06	5.06e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—NOS3—type 1 diabetes mellitus	8.85e-06	5.05e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—IL2—type 1 diabetes mellitus	8.84e-06	5.05e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—HBA1—type 1 diabetes mellitus	8.84e-06	5.05e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—CAT—type 1 diabetes mellitus	8.83e-06	5.04e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—CD80—type 1 diabetes mellitus	8.82e-06	5.04e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—TYK2—type 1 diabetes mellitus	8.82e-06	5.03e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—CD80—type 1 diabetes mellitus	8.8e-06	5.03e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling by GPCR—IL6—type 1 diabetes mellitus	8.8e-06	5.02e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—APOC3—type 1 diabetes mellitus	8.79e-06	5.02e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—NOS3—type 1 diabetes mellitus	8.65e-06	4.94e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—CD80—type 1 diabetes mellitus	8.64e-06	4.93e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—GSTT1—type 1 diabetes mellitus	8.63e-06	4.93e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—TYK2—type 1 diabetes mellitus	8.62e-06	4.92e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—TYK2—type 1 diabetes mellitus	8.58e-06	4.9e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—INS—type 1 diabetes mellitus	8.47e-06	4.84e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—NOS3—type 1 diabetes mellitus	8.46e-06	4.83e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—NOS3—type 1 diabetes mellitus	8.42e-06	4.81e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—TYK2—type 1 diabetes mellitus	8.34e-06	4.76e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—INS—type 1 diabetes mellitus	8.33e-06	4.76e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—INS—type 1 diabetes mellitus	8.32e-06	4.75e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—ALB—type 1 diabetes mellitus	8.31e-06	4.75e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—STAT3—type 1 diabetes mellitus	8.27e-06	4.72e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—CASP3—type 1 diabetes mellitus	8.24e-06	4.71e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—IL2—type 1 diabetes mellitus	8.23e-06	4.7e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—IGF1—type 1 diabetes mellitus	8.19e-06	4.68e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling by GPCR—IL6—type 1 diabetes mellitus	8.19e-06	4.67e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—NOS3—type 1 diabetes mellitus	8.19e-06	4.67e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—INS—type 1 diabetes mellitus	8.16e-06	4.66e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling by GPCR—EGFR—type 1 diabetes mellitus	8.15e-06	4.65e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—STAT3—type 1 diabetes mellitus	8.14e-06	4.65e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—IGF1—type 1 diabetes mellitus	8.06e-06	4.6e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—IGF1—type 1 diabetes mellitus	8.04e-06	4.59e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CD80—type 1 diabetes mellitus	8.03e-06	4.58e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	8.02e-06	4.58e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—EGFR—type 1 diabetes mellitus	8e-06	4.57e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—NOS3—type 1 diabetes mellitus	7.95e-06	4.54e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—IGF1—type 1 diabetes mellitus	7.89e-06	4.51e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	7.85e-06	4.48e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—STAT3—type 1 diabetes mellitus	7.8e-06	4.45e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—INS—type 1 diabetes mellitus	7.58e-06	4.33e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—TYK2—type 1 diabetes mellitus	7.57e-06	4.32e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—CAT—type 1 diabetes mellitus	7.54e-06	4.31e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—EGFR—type 1 diabetes mellitus	7.52e-06	4.29e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—CASP3—type 1 diabetes mellitus	7.51e-06	4.29e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—IL2—type 1 diabetes mellitus	7.5e-06	4.28e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling by GPCR—IL6—type 1 diabetes mellitus	7.46e-06	4.26e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—TYK2—type 1 diabetes mellitus	7.45e-06	4.25e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—STAT3—type 1 diabetes mellitus	7.44e-06	4.25e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—TYK2—type 1 diabetes mellitus	7.43e-06	4.24e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—NOS3—type 1 diabetes mellitus	7.43e-06	4.24e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—EGFR—type 1 diabetes mellitus	7.4e-06	4.23e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—CASP3—type 1 diabetes mellitus	7.35e-06	4.19e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—IL2—type 1 diabetes mellitus	7.34e-06	4.19e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—IGF1—type 1 diabetes mellitus	7.33e-06	4.19e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—NOS3—type 1 diabetes mellitus	7.31e-06	4.17e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling by GPCR—IL6—type 1 diabetes mellitus	7.3e-06	4.17e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	7.3e-06	4.17e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—NOS3—type 1 diabetes mellitus	7.29e-06	4.16e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—TYK2—type 1 diabetes mellitus	7.29e-06	4.16e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—INS—type 1 diabetes mellitus	7.2e-06	4.11e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—CASP3—type 1 diabetes mellitus	7.18e-06	4.1e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—IL2—type 1 diabetes mellitus	7.17e-06	4.09e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—NOS3—type 1 diabetes mellitus	7.16e-06	4.09e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—CASP3—type 1 diabetes mellitus	7.15e-06	4.08e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling by GPCR—IL6—type 1 diabetes mellitus	7.14e-06	4.07e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—IL2—type 1 diabetes mellitus	7.14e-06	4.07e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling by GPCR—IL6—type 1 diabetes mellitus	7.1e-06	4.05e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—EGFR—type 1 diabetes mellitus	7.09e-06	4.05e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—CASP3—type 1 diabetes mellitus	6.95e-06	3.97e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—IL2—type 1 diabetes mellitus	6.94e-06	3.96e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—STAT3—type 1 diabetes mellitus	6.93e-06	3.95e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling by GPCR—IL6—type 1 diabetes mellitus	6.91e-06	3.94e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—GCG—type 1 diabetes mellitus	6.88e-06	3.93e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—TYK2—type 1 diabetes mellitus	6.77e-06	3.87e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—EGFR—type 1 diabetes mellitus	6.76e-06	3.86e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—NOS3—type 1 diabetes mellitus	6.65e-06	3.8e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—ALB—type 1 diabetes mellitus	6.6e-06	3.77e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—NOS3—type 1 diabetes mellitus	6.31e-06	3.6e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—STAT3—type 1 diabetes mellitus	6.31e-06	3.6e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—CASP3—type 1 diabetes mellitus	6.31e-06	3.6e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—IL2—type 1 diabetes mellitus	6.3e-06	3.6e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—EGFR—type 1 diabetes mellitus	6.29e-06	3.59e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling by GPCR—IL6—type 1 diabetes mellitus	6.27e-06	3.58e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—CASP3—type 1 diabetes mellitus	6.21e-06	3.54e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—IL2—type 1 diabetes mellitus	6.2e-06	3.54e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—CASP3—type 1 diabetes mellitus	6.19e-06	3.54e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—IL2—type 1 diabetes mellitus	6.18e-06	3.53e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—STAT3—type 1 diabetes mellitus	6.17e-06	3.52e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling by GPCR—IL6—type 1 diabetes mellitus	6.17e-06	3.52e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—IL6—type 1 diabetes mellitus	6.15e-06	3.51e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—CASP3—type 1 diabetes mellitus	6.08e-06	3.47e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—IL2—type 1 diabetes mellitus	6.07e-06	3.46e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—IL6—type 1 diabetes mellitus	6.04e-06	3.45e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—STAT3—type 1 diabetes mellitus	6.04e-06	3.45e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—STAT3—type 1 diabetes mellitus	6e-06	3.43e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—INS—type 1 diabetes mellitus	5.91e-06	3.37e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—INS—type 1 diabetes mellitus	5.86e-06	3.34e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—STAT3—type 1 diabetes mellitus	5.84e-06	3.33e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—CAT—type 1 diabetes mellitus	5.82e-06	3.32e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—IL6—type 1 diabetes mellitus	5.78e-06	3.3e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—EGFR—type 1 diabetes mellitus	5.73e-06	3.27e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—IL6—type 1 diabetes mellitus	5.69e-06	3.25e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CASP3—type 1 diabetes mellitus	5.65e-06	3.22e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—IL2—type 1 diabetes mellitus	5.64e-06	3.22e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—EGFR—type 1 diabetes mellitus	5.61e-06	3.2e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—IL6—type 1 diabetes mellitus	5.61e-06	3.2e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—EGFR—type 1 diabetes mellitus	5.49e-06	3.13e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—EGFR—type 1 diabetes mellitus	5.46e-06	3.12e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—IL6—type 1 diabetes mellitus	5.45e-06	3.11e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—ALB—type 1 diabetes mellitus	5.42e-06	3.09e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—ALB—type 1 diabetes mellitus	5.37e-06	3.07e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—EGFR—type 1 diabetes mellitus	5.31e-06	3.03e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—STAT3—type 1 diabetes mellitus	5.3e-06	3.03e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—STAT3—type 1 diabetes mellitus	5.21e-06	2.98e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—STAT3—type 1 diabetes mellitus	5.2e-06	2.97e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—IL6—type 1 diabetes mellitus	5.2e-06	2.97e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—NOS3—type 1 diabetes mellitus	5.18e-06	2.96e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—NOS3—type 1 diabetes mellitus	5.14e-06	2.93e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—STAT3—type 1 diabetes mellitus	5.11e-06	2.91e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—INS—type 1 diabetes mellitus	5.01e-06	2.86e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—IL6—type 1 diabetes mellitus	4.84e-06	2.76e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.82e-06	2.75e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—STAT3—type 1 diabetes mellitus	4.74e-06	2.71e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.74e-06	2.71e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.73e-06	2.7e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.64e-06	2.65e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—ALB—type 1 diabetes mellitus	4.59e-06	2.62e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—IL6—type 1 diabetes mellitus	4.41e-06	2.52e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—NOS3—type 1 diabetes mellitus	4.39e-06	2.51e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—IL6—type 1 diabetes mellitus	4.31e-06	2.46e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.31e-06	2.46e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—IL6—type 1 diabetes mellitus	4.22e-06	2.41e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—IL6—type 1 diabetes mellitus	4.19e-06	2.39e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—IL6—type 1 diabetes mellitus	4.08e-06	2.33e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—INS—type 1 diabetes mellitus	3.86e-06	2.21e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—IL6—type 1 diabetes mellitus	3.7e-06	2.11e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—IL6—type 1 diabetes mellitus	3.64e-06	2.08e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—IL6—type 1 diabetes mellitus	3.63e-06	2.07e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—IL6—type 1 diabetes mellitus	3.57e-06	2.04e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—ALB—type 1 diabetes mellitus	3.54e-06	2.02e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—NOS3—type 1 diabetes mellitus	3.39e-06	1.93e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—IL6—type 1 diabetes mellitus	3.31e-06	1.89e-05	CbGpPWpGaD
